[1]Cunningham J, Locatelli F, Rodriguez M.Secondary Hyperparathyroidism:Pathogenesis,Disease Progression,and Therapeutic Options[J].Clinical Journal of the American Society of Nephrology Cjasn, 2011, 6(4):913-21
[2]王莉, 李贵森, 刘志红.中华医学会肾脏病学分会《慢性肾脏病矿物质和骨异常诊治指导》[J].肾脏病与透析肾移植杂志, 2013, 22(6):554-559
[3]Tentori, F, et al..Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis:the DOPPS study[J].[J].Clinical Journal of the American Society of Nephrology Cjasn, 2015, 10(1):98-109
[4]Vazquez-Rodriguez, B I., et al..Metabolic therapy with iodine 131 in patients with chronic renal failure Clinical case[J][J].Enferm Clin, 2015, 25(6):348-54
[5]Cuppari, L.Increased resting energy expenditure in hemodialysis patients with severe hyperparathyroidism[J].Journal of the American Society of Nephrology Jasn, 2004, 15(11):2933-
[6].KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)[J].Kidney Int Suppl, 2009, 113:S1-130-
[7]Nagy E, Mahmoud M, Ghada El annishy, et al.The impact of malnutrition on health‐related quality of life in patients on maintenance hemodialysis[J].[J].Therapeutic Apheresis and Dialysis, 2020, :1744-9979
[8]Rolfson, D B., et al..Validity and reliability of the Edmonton Frail Scale[J][J]..Age& Ageing, 2006, .35(5):526-9
[9]贾彦诺等.慢性肾衰竭继发性甲状旁腺功能亢进的相关因素分析及治疗[J].中国老年学杂志, 2015, 35(11):3182-3184
[10]Masmoudi A, Darouiche M H, Salah H B, et al.Cutaneous abnormalities in patients with end stage renal failure on chronic hemodialysisA study of 458 patients.[J].Journal of Dermatological Case Reports, 2011, 8(4):86-
[11]Dring, B and V.Hipkiss.Managing and treating chronic kidney disease[J].[J].Nurs Times, 2015, 111(7):16-9
[12]He, Y, et al..The browning of white adipose tissue and body weight loss in primary hyperparathyroidism[J][J].EBioMedicine, 2019, 40:56-66
[13]Koppe, L, D.Fouque and K.Kalantar-Zadeh..Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers[J].[J].J Cachexia Sarcopenia Muscle, 2019, 10(3):479-484
[14]Komaba, H and M.Fukagawa..Secondary Hyperparathyroidism and Protein-Energy Wasting in End-Stage Renal Disease[J][J].therapeutic apheresis and dialysis, 2018, 22(3):246-250
[15]Kir, S, et al..PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer[J].Cell Metabolism,, 2016, 23(2):315-23
[16]Kir, S, et al..Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia[J][J].Nature, 2014, 513(7516):100-4
[17]Wyatt, C M.and W.E.Mitch..In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator ofcachexia[J].[J].Kidney International, 2016, 89(5):973-975
[18]陈香美, 倪兆慧, 刘玉宁, 等.慢性肾衰竭中西医结合诊疗指南[J].[J].中国中西医结合杂志, 2015, (09):1029-1033
|